Product Details

• Modular Combination Design

  The main unit can be flexibly paired with a variety of functional components …Its compact design supports on-demand configurations, and can adapting to various on-site environment and installation methods.

• User-Friendly

  Integrated "Cassette-Tape" Type Cartridge Design, eliminating the need for complex tubing connections and inspections, enables quick installation and removal. Paired with a user-friendly operating software, it is simple and easy to operate.

• Safety Protection

  The liquid pathway in the cartridge achieves 100% isolation from the main unit. After cartridge removal, the main unit retains no radioactive residue, making it suitable for labeling with long-half-life radionuclides.

• Powerful Functionality

  
  

  The operating software is pre-loaded with radiolabeling protocols for nuclides such as ⁶⁸Ga, ⁸⁹Zr, ⁶⁴Cu, ¹⁷⁷Lu, ¹⁸F, ⁹⁹mTc, ¹³¹I; Includes dozens of mature tracer synthesis protocols for direct use.

  
  

  
  

  
  

Product Portfolio

Weight

Dimensions (W x H x D)

Function

ZM00101

18.55 kg (40.9 lbs)

30.5 × 45.1 × 40.6 cm (12.0 × 17.8 × 16.0 inch)

Multifunction Modular Syntheisizer for Radiolabeled Products

ZM00102

5.32 kg(11.73 lbs)

27.2 × 15.3 × 31.2 cm (10.7 × 6.0 × 12.3 inch)

Module for purification

ZM00103

3.69 kg (8.14 lbs)

28.1 × 19.5 × 21.2 cm (11.1 × 7.7 × 8.4 inch)

Module for waste gas handling

ZM00104

5.43 kg (11.97 lbs)

30.7 × 19.0 × 20.8 cm (12.1 × 7.5 × 8.2 inch)

Module for sub-packaging

Product Videos

From radionuclide separation and purification to automated radiopharmaceutical synthesis, our video offers a direct look at how Mortenon M1 is reshaping nuclear medicine production—delivering faster, safer, and smarter operations.

Customer Reviews

Radiochemist

A radiopharmaceutical startup company

Thanks to the seamless integration of the Mortenon M1 automated synthesis module with its single-use cassette system, our laboratory is able to efficiently carry out consecutive syntheses of multiple radiopharmaceuticals, fully supporting the company's development of novel tracers. The system delivers stable yields and reliable performance.
We have successfully produced multiple batches of 68Ga- and 177Lu-labeled radiopharmaceuticals targeting urologic tumors to meet the supply needs for Phase I/II clinical studies.

Director of Nuclear Medicine Department

A tertiary referral hospital

Radiopharmaceuticals are the foundation of molecular imaging in nuclear medicine and precision diagnosis and therapy. They are the result of the integrated interaction among radionuclides, targeting molecules, and automated synthesis equipment. The diversified, specific, high-quality, and highly stable synthesis and supply of radiopharmaceuticals play a critical role in ensuring the smooth operation of PET centers.

Q&A

• Can the Mortenon M1 accommodate customized workflows from partners?

  
  The Mortenon M1 was designed from the outset with a strong emphasis on scalability and compatibility. We support co-development with partners to create customized cassettes and synthesis protocols, ensuring the system maintains high technical adaptability and forward compatibility throughout product iteration cycles. In other words, the Mortenon M1 is not just an automated device — it is a future-ready, continuously evolving platform for radiopharmaceutical production.
• What does the after-sales service for Mortenon M1 include?

  
  We provide comprehensive after-sales services for the Mortenon M1, including equipment installation and commissioning, operator training, regular maintenance, troubleshooting, and remote technical support. Additionally, spare parts are supplied promptly to ensure stable and worry-free operation. Our service team responds quickly, and users can contact us anytime via hotline, email, or other channels. We will arrange timely support based on the situation to ensure the equipment runs efficiently and reliably.